US Patent Issued to SOLEY THERAPEUTICS on Nov. 11 for "Phthalazinone based modulators for the treatment of disease" (British Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,603, issued on Nov. 11, was assigned to SOLEY THERAPEUTICS INC. (South San Francisco, Calif.).

"Phthalazinone based modulators for the treatment of disease" was invented by Nadia Mamoona Ahmad (Essex, Great Britain), Christopher Charles Rennie (Essex, Great Britain), William Rameshchandra Krishna Esmieu (Saffron Walden, Great Britain), Mark Chambers (Saffron Walden, Great Britain), Toby Jonathan Blench (Essex, Great Britain), Susan Mary Cramp (Essex, Great Britain), Toby Matthew Grover Mullins (Essex, Great Britain), Terry Aaron Panchal (Essex, Great Britain) and Joseph Leo Mckenna (Essex, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: ...